Celldex Therapeutics, Inc. (CLDX)
$29.43-1.54%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.0B
- Beta
- 0.90
- P/E (TTM)
- -7.11
- Short % float
- 17.94%
- Days to cover
- 3.8
- SI change
- +22.9%
- 1W
- -9.70%
- 1M
- -20.24%
- vs SPY 1W
- -10.12%
- vs SPY 1M
- -22.30%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CLDX?
- LOPJLB’s latest quantitative signal on Celldex Therapeutics, Inc. (CLDX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLDX in?
- Celldex Therapeutics, Inc. (CLDX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Celldex Therapeutics, Inc. (CLDX) do?
- Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to a…